Generate Investment Management’s AbbVie ABBV Stock Holding History

Generate Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14M	Buy	55,571 +23,387	+73%	+$5.03M	0.58%	44
2026 Q1	$7M	Sell	32,184 -5,261	-14%	-$1.17M	0.34%	50
2025 Q4	$8.56M	Sell	37,445 -49,224	-57%	-$11.2M	0.39%	60
2025 Q3	$20.1M	Buy	86,669 +41,472	+92%	+$8.45M	1.02%	31
2025 Q2	$8.39M	Buy	+45,197	New	+$8.4M	0.47%	60
2025 Q1	–	Sell	-47,324	Closed	-$8.41M	–	78
2024 Q4	$8.41M	Buy	+47,324	New	+$8.7M	0.59%	59
2024 Q2	–	Sell	-26,935	Closed	-$4.9M	–	76
2024 Q1	$4.9M	Buy	+26,935	New	+$4.64M	0.36%	72

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Generate Investment Management's ABBV Position: Q2 2026 in Review

Generate Investment Management increased its AbbVie (ABBV) stake by 73% in Q2 2026, buying an estimated $5.03M and bringing the position to 55,571 shares worth $14M. The position accounts for 0.58% of the portfolio, ranked #44.

Generate Investment Management first reported a position in ABBV in Q1 2024 and has held it in 7 quarters since. The position peaked at $20.1M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Generate Investment Management held 55,571 shares of AbbVie worth $14M as of Q2 2026.
Generate Investment Management bought 23,387 AbbVie shares in Q2 2026, an estimated $5.03M.
AbbVie made up 0.58% of Generate Investment Management's portfolio in Q2 2026, its #44 holding.
Generate Investment Management first reported a position in AbbVie in Q1 2024 and has held it in 7 quarters since.
Generate Investment Management's AbbVie position peaked at $20.1M in Q3 2025.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Generate Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.